Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.

Schneider, Pauline; Crump, Nicholas T; Arentsen-Peters, Susan T C J M; Smith, Alastair L; Hagelaar, Rico; Adriaanse, Fabienne R S; Bos, Romy S; de Jong, Anja; Nierkens, Stefan; Koopmans, Bianca; Milne, Thomas A; Pieters, Rob; Stam, Ronald W

Schneider, Pauline; Crump, Nicholas T; Arentsen-Peters, Susan T C J M; Smith, Alastair L; Hagelaar, Rico; Adriaanse, Fabienne R S; Bos, Romy S; de Jong, Anja; Nierkens, Stefan; Koopmans, Bianca; Milne, Thomas A; Pieters, Rob; Stam, Ronald W.

Afiliação

Schneider P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Crump NT; MRC Molecular Haematology Unit, Radcliffe Department of Medicine, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Arentsen-Peters STCJM; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
Smith AL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Hagelaar R; MRC Molecular Haematology Unit, Radcliffe Department of Medicine, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Adriaanse FRS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Bos RS; Oncode Institute, Utrecht, The Netherlands.
de Jong A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Milne TA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Stam RW; MRC Molecular Haematology Unit, Radcliffe Department of Medicine, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Exp Hematol Oncol ; 12(1): 81, 2023 Sep 22.

Article em En | MEDLINE | ID: mdl-37740239

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda